Korea’s ViroMed acquires DNA-producing facility for clinical trial in U.S.
ViroMed, a Korean developer of biologic drugs, Wednesday announced it has acquired a DNA production facility in San Diego, California,…
Sanofi to invest €350 million in Canadian vaccine facility
Expansion demonstrates company’s commitment to innovation and leadership in global public health New Toronto facility is one of the largest-ever…